TSS
BIOC

Two Sigma Securities’s Biocept, Inc. BIOC Stock Holding History

Two Sigma Securities’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,718
Closed -$15.9K – 3814
2023
Q3 		$15.9K Buy
+12,718
New +$15.3K ﹤0.01% 2609
2020
Q3 		– Sell
-77
Closed -$16K – 1735
2020
Q2 		$16K Buy
+77
New +$11K ﹤0.01% 1296
2020
Q1 		– Sell
-130
Closed -$11K – 2519
2019
Q4 		$11K Buy
+130
New +$22.4K ﹤0.01% 2273
2019
Q2 		– Sell
-92
Closed -$32K – 2514
2019
Q1 		$32K Buy
92
+32
+53% +$13K ﹤0.01% 1640
2018
Q4 		$16K Buy
+60
New +$30.1K ﹤0.01% 1986
2018
Q2 		– Sell
-5
Closed -$14K – 3110
2018
Q1 		$14K Buy
5
+1
+25% +$3.75K ﹤0.01% 2597
2017
Q4 		$28K Buy
4
+3
+300% +$23.7K ﹤0.01% 1600
2017
Q3 		$15K Buy
+1
New +$11.8K ﹤0.01% 849
2016
Q3 		– Hold
0
– -$7K – 816
2016
Q2 		– Hold
0
– – – 405

Two Sigma Securities's BIOC Position: Q4 2023 in Review

Two Sigma Securities sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 12,718 shares — an estimated $15.9K sold.

Two Sigma Securities first reported a position in BIOC in Q3 2017 and held it in 8 quarters. The position peaked at $32K in Q1 2019. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.

  • Two Sigma Securities reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 12,718 Biocept, Inc. shares in Q4 2023, an estimated $15.9K.
  • Two Sigma Securities first reported a position in Biocept, Inc. in Q3 2017 and held it in 8 quarters.
  • Two Sigma Securities's Biocept, Inc. position peaked at $32K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.